Evidence map›Paper›PMID 22717452›Full record

ArticleGut2013

Fibroblast growth factor inducible 14 as potential target in patients with alcoholic hepatitis.

Bernd Schnabl, David A Brenner

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Bernd SchnablDepartment of Medicine, University of California San Diego, MC0702, 9500 Gilman Drive, La Jolla, CA 92093, USA. beschnabl@ucsd.edu
David A Brenner

Funding

Microbiome and intestinal innate immune response in alcoholic liver diseaseR01AA020703 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHNABL, BERND G. · 2011 to 2020
$3.6M
TNF ALPHA AND IMPAIRED WOUND HEALING OF CACHEXIA XIAR01GM041804 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI BRENNER, DAVID A. · 1989 to 2013
$3.4M
Blocking toll-like receptor 4 signaling as therapy in hepatic fibrosisK08DK081830 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHNABL, BERND G. · 2009 to 2013
$707k
NIAAA NIH HHS R01 AA020703NIDDK NIH HHS K08 DK081830NIGMS NIH HHS R01 GM041804
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsFemaleGene Expression RegulationHepatitis, AlcoholicHumansMaleReceptors, Tumor Necrosis FactorTWEAK ReceptorReceptors, Tumor Necrosis FactorTNFRSF12A protein, humanTWEAK Receptor

Identifiers

PMID22717452
PMCPMC4077319

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.